Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Nofimanology market was valued at 3850 Million US$ in 2018 and is projected to reach 5351 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.2% during the forecast period.
This report presents the market size and development trends by detailing the Nofimanology market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Nofimanology market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Nofimanology industry and will help you to build a panoramic view of the industrial development.
Nofimanology Market, By Type:
Marine Animal Technolog
Marine Plant Technology
Nofimanology Market, By Application:
Foods
Nutraceuticals
Medicine
Cosmetics
Research Tools
Processing Technologies
New Energy Sources
Agriculture
Industrial
Food Safety
Some of the leading players are as follows:
New England Biolabs Inc (US)
NEB Pty Ltd (Australia)
PML Applications Ltd. (UK)
PharmaMar S.A (Spain)
NovaMatrix (Norway)
BioLume(r), Inc. (US)
Cyanotech Corp. (US)
BiotechMarine Ltd. (UK)
Royal DSM N.V (Netherlands)
OceanBASIS GmbH (Germany)
BASF SE (Germany)
Nutrex Hawaii (US)
CP Kelco (US)
Jazz Pharmaceuticals plc (Ireland)
FMC Health and Nutrition (US)
Lonza Group Ltd. (Switzerland)
Prolume Ltd (US)
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Nofimanology Market: Technology Type Analysis
-
4.1 Nofimanology Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Nofimanology Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Marine Animal Technolog
4.3.2 Marine Plant Technology
5 Nofimanology Market: Product Analysis
-
5.1 Nofimanology Product Market Share Analysis, 2018 & 2026
-
5.2 Nofimanology Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Nofimanology Market: Application Analysis
-
6.1 Nofimanology Application Market Share Analysis, 2018 & 2026
-
6.2 Nofimanology Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Foods
6.3.2 Nutraceuticals
6.3.3 Medicine
6.3.4 Cosmetics
6.3.5 Research Tools
6.3.6 Processing Technologies
6.3.7 New Energy Sources
6.3.8 Agriculture
6.3.9 Industrial
6.3.10 Food Safety
7 Nofimanology Market: Regional Analysis
-
7.1 Nofimanology Regional Market Share Analysis, 2018 & 2026
-
7.2 Nofimanology Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 New England Biolabs Inc (US)
9.1.1 New England Biolabs Inc (US) Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 NEB Pty Ltd (Australia)
9.2.1 NEB Pty Ltd (Australia) Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 PML Applications Ltd. (UK)
9.3.1 PML Applications Ltd. (UK) Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 PharmaMar S.A (Spain)
9.4.1 PharmaMar S.A (Spain) Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 NovaMatrix (Norway)
9.5.1 NovaMatrix (Norway) Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 BioLume(r), Inc. (US)
9.6.1 BioLume(r), Inc. (US) Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Cyanotech Corp. (US)
9.7.1 Cyanotech Corp. (US) Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 BiotechMarine Ltd. (UK)
9.8.1 BiotechMarine Ltd. (UK) Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Royal DSM N.V (Netherlands)
9.9.1 Royal DSM N.V (Netherlands) Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 OceanBASIS GmbH (Germany)
9.10.1 OceanBASIS GmbH (Germany) Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 BASF SE (Germany)
9.11.1 BASF SE (Germany) Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Nutrex Hawaii (US)
9.12.1 Nutrex Hawaii (US) Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 CP Kelco (US)
9.13.1 CP Kelco (US) Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Jazz Pharmaceuticals plc (Ireland)
9.14.1 Jazz Pharmaceuticals plc (Ireland) Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 FMC Health and Nutrition (US)
9.15.1 FMC Health and Nutrition (US) Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Lonza Group Ltd. (Switzerland)
9.16.1 Lonza Group Ltd. (Switzerland) Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 Prolume Ltd (US)
9.17.1 Prolume Ltd (US) Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
The List of Tables and Figures (Totals 98 Figures and 133 Tables)
Figure Marine Animal Technolog Nofimanology market, 2015 - 2026 (USD Million)
Figure Marine Plant Technology Nofimanology market, 2015 - 2026 (USD Million)
Figure Foods market, 2015 - 2026 (USD Million)
Figure Nutraceuticals market, 2015 - 2026 (USD Million)
Figure Medicine market, 2015 - 2026 (USD Million)
Figure Cosmetics market, 2015 - 2026 (USD Million)
Figure Research Tools market, 2015 - 2026 (USD Million)
Figure Processing Technologies market, 2015 - 2026 (USD Million)
Figure New Energy Sources market, 2015 - 2026 (USD Million)
Figure Agriculture market, 2015 - 2026 (USD Million)
Figure Industrial market, 2015 - 2026 (USD Million)
Figure Food Safety market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Nofimanology market, by country, 2015 - 2026 (USD Million)
-
Table North America Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table North America Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table North America Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table Canada Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table Canada Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Europe Nofimanology market, by country, 2015 - 2026 (USD Million)
-
Table Europe Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table Europe Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table Europe Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table Germany Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table Germany Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table France Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table France Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table Italy Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table Italy Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table Spain Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table Spain Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Nofimanology market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table China Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table China Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table Japan Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table Japan Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table India Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table India Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Nofimanology market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table MEA Nofimanology market, by country, 2015 - 2026 (USD Million)
-
Table MEA Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table MEA Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table MEA Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Nofimanology market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Nofimanology market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Nofimanology market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table New England Biolabs Inc (US) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table NEB Pty Ltd (Australia) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table PML Applications Ltd. (UK) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table PharmaMar S.A (Spain) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table NovaMatrix (Norway) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BioLume(r), Inc. (US) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cyanotech Corp. (US) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BiotechMarine Ltd. (UK) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Royal DSM N.V (Netherlands) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table OceanBASIS GmbH (Germany) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table BASF SE (Germany) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Nutrex Hawaii (US) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CP Kelco (US) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Jazz Pharmaceuticals plc (Ireland) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table FMC Health and Nutrition (US) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Lonza Group Ltd. (Switzerland) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Prolume Ltd (US) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
